Catalyst Wire Dossier Catalyst Wire Dossier

ABT-335 (Choline Fenofibrate)

Choline fenofibrate · Abbott Laboratories
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABT-335 (Choline Fenofibrate), covering 2011-04-20 to 2011-04-20. Get the full timeline:

Most recent: Clinical Trial Update: ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study [Phase 1, Phase 2]

See pricing